CVMA-ACMV

News & Events

Health Canada Stakeholder Engagement Webinars on Good Manufacturing Practices Guide for Drug Products and More

August 21, 2018

Health Canada held Stakeholder Engagement Webinars in June 2018 pertaining to the Good manufacturing practices guide for drug products (GUI-0001), the Risk classification guide for drug good manufacturing practices observations (GUI-0023) and the Annex 1 to the Good manufacturing practices guide – Manufacture of sterile products (GUI-0119) in addition to updates on the Drug GMP Inspection Program.

Health Canada is pleased to make available copies of the webinar presentation and the presentation recordings.

English Web Recording: https://gts-ee.webex.com/gts-ee/onstage/playback.php?RCID=082769f7ef0fad568c9698a09de3380c


Further Information

For questions related to Good Manufacturing Practices requirements, please contact the Good Manufacturing Practices Inspection Headquarters at: hc.drug.gmp.questions-bpf.medicaments.sc@canada.ca.

For questions related to the Drug Establishment Licensing Requirements, please contact the Drug Establishment Licensing Unit at: hc.del.questions-leppp.sc@canada.ca.

For importers with questions related to submissions in support of demonstrating GMP compliance of foreign buildings where licensable activities are conducted with respect to drugs, please contact: hc.foreign.site-etranger.sc@canada.ca.